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Low-dose tolerance using heat-killed mycobacteria has been tested as a means of
stopping progression toward active tuberculosis (TB) lesions in a human-like murine
model using C3HeB/FeJ mice. In the present study, we studied the effect of different
treatment schedules with heat-killed non-tuberculous-mycobacteria (NTM) species when
given orally, based on the hypothesis of generating oral tolerance. This study included
M. manresensis, a new species belonging to the fortuitum group, present in drinking
water. Oral treatment with M. manresensis for 2 weeks was able to induce a PPD-
specific Tregs population, which has been related to a decrease in the neutrophilic
infiltration found in TB lesions. Further mechanistic analysis using PPD-stimulated
splenocytes links this 2-week treatment with heat-killed M. manresensis to IL-10
production and memory PPD-specific Tregs, and also to a weak PPD-specific global
immune response stimulation, increasing IL-6, TNF, and IFN-γ production. In lungs, this
treatment decreased the bacillary load, granulomatous infiltration and pro-inflammatory
cytokines (TNF, IFN-γ, IL-6, and IL-17). Oral administration of M. manresensis during
standard treatment for TB also significantly reduced the relapse of active TB after ending
the treatment. Overall the data suggest that the use of heat-killed M. manresensis could
be a new and promising tool for avoiding active TB induction and as adjunctive to TB
treatment. This supports the usefulness of generating a new kind of protection based
on a complex balanced immune response focused on both destroying the bacilli and
including control of an excessive inflammatory response.
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INTRODUCTION
Tuberculosis (TB) is a major global health problem, with 9 million new TB cases and 1.5 million
deaths reported in 2013 (WHO, 2014). It is estimated that one third of the world’s population is
infected with latent tuberculosis infection (LTBI). Fortunately, only a small proportion of infected
subjects go on to develop the disease. Although, some host factors, mainly immunosuppression
conditions such as human immunodeficiency virus (HIV) coinfection, drug abuse, renal failure or
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diabetes mellitus, are known to be related to generation of the
disease, it still remains unclear why almost half of healthy adult
cases develop TB.
As reviewed recently (Vilaplana and Cardona, 2014), research
efforts to develop new treatment or preventive strategies have
focused on destruction of the bacilli by identifying metabolic
pathway targets (development of antimicrobial agents) or
studying how the host’s immune system identifies it (new vaccine
development), whereas little effort has been invested in trying
to modulate the host’s response against the bacilli, which is
paramount for understanding the development of infectious
diseases (Casadevall and Pirofski, 2003), with TB not being an
exception (Cardona, 2010).
Understanding the infection’s progression to active TB is
essential for finding new strategies to fight TB. In this regard,
induction of liquefaction in TB lesions has been identified as a
key factor that allows extracellular growth of the bacilli and the
development of cavities, thereby favoring spread of the infection
(Grosset, 2003; Cardona, 2011). For this reason, we developed
a murine model of active TB using a C3HeB/FeJ mice strain in
which lesions liquefact, thus mimicking human-like progression
(Marzo et al., 2014). Characterization of this model showed us
that extracellular bacillary growth starts before the liquefaction
process and is fuelled by the constant attraction of neutrophils
and the induction of Neutrophilic Extracellular Traps (NETs),
thereby starting a local and uncontrollable bacillary spread. This,
in turn, allows fast growth of the granulomas, the induction of
new lesions and the coalescence of neighboring lesions, which
are responsible for the logarithmic growth of the granulomas.
Once a certain size is exceeded, the center of the granulomas
first develops caseous necrosis and then the caseum softens,
thus leading to liquefaction (Marzo et al., 2014; Vilaplana and
Cardona, 2014). In this regard, a recent review of the pathology
of human lesions based on necropsies from the pre-antibiotic era
also highlights the key role of neutrophils as inducers of exudative
lesions, which are clearly responsible for the progression toward
active TB (Cardona, 2015). In summary, we can conclude that the
onset of active TB is a consequence of an excessive inflammatory
response and the coalescence of different lesions (Vilaplana and
Cardona, 2014).
Evidence for the key role of inflammation in progression to
TB disease has also been reported by others. Thus, a detrimental
role of excessive accumulation of neutrophils has been described
in mice (Eruslanov et al., 2005; Keller et al., 2006) and, in
humans, genetic studies performed with TB and leprosy patients
indicated that insufficient but also excessive inflammation are
key to TB pathogenesis (Tobin et al., 2010). Similarly, Berry
et al. found a signature of active TB that measures interferon
IFN type I-inducible genes in whole blood (Berry et al., 2010).
Unexpectedly, the genes induced in susceptible population were
expressed in neutrophils and not in T-cells, thus suggesting that
over-activation of neutrophils by IFNs may contribute to TB
pathogenesis.
Host-Directed Therapies (HDT) are currently becoming
increasingly popular, as reviewed by Hawn et al. (2013), Zumla
et al. (2015), and Zumla and Maeurer (2015). In this regard, we
previously tested ibuprofen (Vilaplana et al., 2013) and other
non-steroidal anti-inflammatory drugs (NSAID) (Marzo et al.,
2014) in the C3HeB/FeJ model, with very promising results. We
are now exploring their potential therapeutic use in humans,
but as NSAIDs can produce adverse effects related to dose and
length of treatment, these should be taken into account when
considering long-term therapy (Michels et al., 2012; Bjarnason,
2013).
After the success obtained with the aforementioned anti-
inflammatory treatment, and for safety reasons, we decided to
look for a strategy that avoids the potential toxicity of these
drugs and the perspective of constant administration to obtain
an effective prophylactic effect. The prophylactic/therapeutic
use of low dose tolerance to avoid an excessive inflammatory
response has been widely used by different authors in the field
of experimental autoimmune encephalitis (Ochi et al., 2006),
diabetes mellitus and other autoimmune diseases (Weiner et al.,
2011), as well as infectious diseases (Levy and Ilan, 2007) and
atherosclerosis (Harats et al., 2002). The role of regulatory T
cells (Tregs) in TB has been controversial as they were initially
thought to fuel progression toward active TB. However, recent
reports seem not to support this idea (Green et al., 2010;
Leepiyasakulchai et al., 2012), thus leading to a more neutral role
in their interference against the Th1 response.
METHODOLOGY
Experimental Design
We first conducted a proof-of-concept study to assess the role
of Tregs in protection against the development of active TB by
comparing the susceptible strain (C3HeB/FeJ) with the resistant
one (C3H/HeN). We then tested the usefulness of low-dose heat-
killedMycobacterium tuberculosis (Mtb) cells and their protective
role. Finally, we tested different environmental NTM species in
order to ensure any possible transfer of this strategy to the market
and further characterized the effect of the species that provided
the best results.
Animals
Female C3HeB/FeJ and C3H/HeN specific-pathogen-free mice
(6–8 weeks old) were obtained from Jackson Laboratories (Bar
Harbor, Maine, USA) and Harlan Labs (Castellar del Vallès,
Catalonia, Spain). All procedures were conducted in a BL3
security facility. Mice were infected with 2 × 104 CFU of
M. tuberculosisH37Rv Pasteur strain via the caudal vein.
All procedures were performed according to protocol
DMAH6119, which was reviewed by the Animal
Experimentation Ethics Committee of the Hospital Universitari
Germans Trias i Pujol (registered as B9900005) and approved
by the Dept d’Agricultura, Ramaderia, Pesca, Alimentació
i Medi Natural of the Catalan Government, according to
current national and European Union legislation regarding
the protection of experimental animals (Law 1997 of the
Catalan Government; Spanish Royal Decree 1201/2005; and
European legislation 86/609/EEC; 91/628/EEC; 92/65/EEC and
90/425/EEC).
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Mice were supervised daily and euthanized, if required, with
isoflurane (inhalation excess), following a strict protocol, in order
to ensure animal welfare.
Study of the Role of Tregs in Protection
Against the Development of Active TB
To study the role of Tregs in TB, three experiments were
performed with C3HeB/FeJ and C3H/HeN mice. First, 6 mice
from each strain were infected and sacrificed at 3 weeks post-
infection to evaluate Treg population in spleen. This experiment
was repeated with a final time point of week 2 post-infection,
the splenocytes collected being cultured for 7 days. In the third
experiment, a total of 12 C3H/HeN mice were infected, and
one group was Treg-depleted in vivo by administration of anti-
mouse CD25 antibody (Clone PC61.5, eBioscience Inc. San
Diego, CA) the day before the infection. Blood was collected
at different time points to evaluate Treg depletion by flow
cytometry. Animals were sacrificed at day 46 post-infection to
evaluate lung histopathology.
Treatment Preparation
Different mycobacteria from the Experimental Tuberculosis Unit
strain collection, namely M. tuberculosis, M. kansasii, M. avium,
and M. manresensis (new species, Rech et al., 2015 CECT 8638)
were used to prepare the treatments.M. bovis BCGDanish (Pfizer
Inc., NY, USA) was also used. Bacteria were grown in 7H11
plates (BCG, M. kansasii, and M. manresensis) or in Proskauer-
Beck broth (M. tuberculosis and M. avium) and subcultured in
Proskauer-Beck broth (or in 7H11 plates, for M. manresensis)
in aeration and agitation at 37◦C. The bacillary load (BL) of
each culture was determined by serial dilution and culture on
7H11 plates, and a Blood Agar plate was also seeded to rule out
contamination. Cultures were then inactivated by heating at 80◦C
for 60min. Sterilization was confirmed by negative culture in
7H11 (10 plates), Blood Agar, McConkey Agar, and Saboureaud
Agar. The inactivated cultures were diluted 1:1 in sterile sucrose
(10% sucrose in water) and aliquoted in 1ml vials for storage
at−80◦C.
Assessment of Treatments
The effect of treatment on the survival of infected mice was
studied. This assessment was done for each treatment when given
prophylactically and therapeutically at different doses (103–106
heat-killed bacilli/animal) and administration schedules (every
day, every other day, three times-a-week). The results presented
here were repeated 3 times, using 10 C3HeB/FeJ mice per group
(a total of 120 animals).
In order to further characterize the effect of treatment,
we evaluated several parameters at week 3 post-infection.
For this purpose a total of 20 C3HeB/FeJ mice were used
(5 per group of treatment). Animals received seven oral
doses of M. tuberculosis (105 heat-killed bacilli/animal),
BCG (106 heat-killed bacilli/animal), and M. manresensis
(105 heat-killed bacilli/animal) every other day from
the day of infection and were sacrificed at day 21 post-
infection. At the final time point, pathology and BL in
lungs, and effect on T cell populations were studied (see
Sections 2.6 to 2.8). A control group was included and
treated with the corresponding dilution of the excipient
(mannitol).
The oral administration of heat-killed mycobacteria as a
coadjuvant therapy to the human standard treatment against
active TB (a combination of rifampicin, isoniazid, ethambutol,
and pyrazinamide (RHEZ)) was also studied. A total of 21
C3HeB/FeJ mice were used. They started to be treated at week
4 post-infection, when their weight started to decrease. All
animals received a commercial combination of the four drugs
(RIMSTAR R©, Sandoz Farmaceutica, Barcelona) adjusted to their
weight, for a total of 4 weeks. Half of the animals also received
heat-killedM. manresensis (105 heat-killed bacilli/animal) orally,
5 days a week for a total of 6 weeks (in addition to the 4-
week-treatment with RHEZ, plus 2 more weeks). At the final
time point, pathology in lungs was studied (see Section Lung
Pathology).
Bacillary Load
Samples of lung lobes from each animal were collected,
homogenized and several dilutions plated on nutrient
Middlebrook 7H11 agar (BD Diagnostics, Spark, USA).
The number of CFU was counted after incubation for 28 days at
37◦C and the results expressed as CFU/mL.
Lung Pathology
Lungs were fixed in 10% buffered formalin, embedded in
paraffin and 5-µm sections stained with haematoxylin-eosin
(HE), Masson trichromic (MTC) or Ziehl-Neelsen (ZN) stain for
microscopic observation and histometric analysis using the NIS-
Elements D version 3.0x software package (Nikon Instruments
Inc., Tokyo, Japan). Eight recuts of half-lung of each mice stained
withHEwere used to determine the damaged area as a percentage
of total lung area.
Immuno-Characterization
Cell Isolation and Cell Cultures
Spleens were mechanically disrupted and filtered through a 40-
µm cell strainer (BD Diagnostics, Spark, USA), with erythrocytes
being incubated for 8min in lysis buffer (Tris 17mM, NH4Cl
0.14 M). 106 cells were either directly stained for flow
cytometric analysis or cultured, depending on the experiment.
Cell culture was conducted in supplemented RPMI 1640 (10%
Fetal Calf Serum, streptomycin 100µg/ml, penicillin 100 U/ml,
2-mercaptoethanol 0.025mM, sodium pyruvate 1mM) in 24-
well plates at 37◦C and 5% CO2, with or without PPD
stimuli (final concentration of 10µg/ml; Statens Serum Institute,
Kobenhavn, Denmark). After 24 h, 4 days, or 7 days of culture,
the content of each well was harvested and stained for flow
cytometric analysis. Culture supernatants were stored at −80◦C
for further study of the cytokine profile. Lungs were snap-frozen
when collected and kept stored at −80◦C until processed for
cytokine profile analysis. They were then subjected to mechanical
disruption and homogenized with lysis buffer (sodium azide
0.05%, Triton X-100 0.5%, protease inhibitor cocktail from
Sigma at 1:500, in PBS; Sigma-Aldrich Co. LLC, St. Louis, MO,
USA).
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PPD-Specific T Cell Population Analysis by Flow
Cytometry
Mouse Regulatory T Cell Staining Kit #2 (eBioscience Inc., SD,
USA) was used for intracellular staining (Foxp3) according to
the manufacturer’s indications. For membrane staining, cells
were incubated for 30min at 4◦C with the antibodies, followed
by fixation with 4% formaldehyde in PBS for 10min at room
temperature.
PPD-specific T cell populations, obtained from spleen cultures
at 24 h, 4 days, or 7 days, were studied by flow cytometry.
Different CD4+ T cell types, namely CD25+CD39+ Regulatory
Memory T cells; CD25-CD39+ Effector Memory T cells, ex-
Tregs IL-17 producers; CD25+CD39− T Effector cells and
CD25-CD39− Naïve T cells, according to Dwyer et al.’s
characterization (Dwyer et al., 2010), were studied.
The antibodies used were anti-mouse CD4 FITC, anti-mouse
CD25 PE and anti-mouse Foxp3 APC (eBioscience Inc., SD,
USA), anti-mouse CD3e BV™421, anti-mouse CD25-PerCP-
CyTM5.5 (BD biosciences, CA, USA) and anti-mouse CD39 PE
(BioLegend Inc., CA, USA).
Once stained, samples were read in a flow cytometer (BD
LSRFortessa™, BD Biosciences, CA, USA). Data were analyzed
using FACSdiva™ software (BD Biosciences, CA, USA; Figure 1).
Cytokine Profile Analysis
A cytokine profile study was performed in splenocyte culture
supernatant and lung homogenates. The following cytokines
were measured by Luminex xMAP R© technology: IFNγ, TNFα,
IL-5, IL-6, IL-10, IL-13, and IL-17. Results were expressed
as pg per ml of supernatant. The assay was performed with
the MILLIPLEX R© MAP kit (EMD Millipore Corporation,
Billerica, MA, USA) following the manufacturer’s instructions
and analyzed with xPONENT Software (Luminex Corporation,
Austin, TX, USA).
Data Analysis
GraphPad Prism version 5.00 forWindows, (GraphPad Software,
San Diego California USA) was used for graphics and statistics,
with differences of p < 0.05 being considered to be statistically
significant.
RESULTS
Protective Role of Regulatory T Cells (Treg)
In order to study the mechanisms that modulate the
inflammation in active TB, the Treg population was studied in
C3HeB/FeJ mice and compared with the TB-resistant mouse
strain C3H/HeN. Mice from both strains were infected IV and
the Treg population in spleen studied by flow cytometry 3 weeks
post-infection. As shown in Figure 2A, the median percentage of
Treg (CD4+CD25+Foxp3+ cells) out of total CD4+ in spleen
was higher in C3H/HeN than in C3HeB/FeJ mice (C3H/HeN:
10.28%, C3HeB/FeJ: 8.09%; t-test, p = 0.0022). The same
experiment was repeated with the animals being sacrificed at day
14 and the resulting splenocytes cultured and PPD-stimulated.
The C3H/HeN resistant mice had higher basal and PPD-specific
Treg percentage in culture compared to C3HeB/FeJ mice, as
shown in Figure 2B. Intergroup differences were statistically
significant (p < 0.05, Mann Whitney test).
In the third experiment, C3H/HeN mice were depleted of
Treg cells by administration of anti-CD25 prior to Mtb infection.
All animals treated were effectively depleted of Treg cells, as
shown in Figure 2C, except for one animal, which was excluded
from the analysis. One animal from the Treg-depleted group was
sacrificed at day 32 for ethical reasons as it exhibited a marked
TB infection in the lungs. The remaining animals were sacrificed
at day 46 as scheduled and their lung pathology assessed by
qualitative and quantitative (histometry) histological analysis.
The histometry showed differences in the percentage of damaged
lung area between both groups (not statistically significant)
(Figure 2D). The results for the Treg-depleted group were highly
scattered: three animals had a similar percentage of damaged lung
area to the controls (20–40%), whereas the other two animals
had a higher percentage of damaged area (around 80%). The
qualitative analysis matched these findings: the animals withmild
TB infection (less than 40% of damaged lung area) presented
medium size lesions with no signs of necrosis or other forms of
cell death, with mainly macrophage and lymphocyte infiltration,
and scattered neutrophils around foamy macrophages, while
those with severe TB infection (more than 75% of damaged lung
area) presented very big lesions with central caseous necrosis and
liquefaction (Figure 2F). When classifying the animals according
to the degree of lung affection it was found that the frequency
of severe affection (>75% of damaged lung) was 0 in the control
group and 2/5 in the depleted group (Figure 2E; p < 0.1, z-test
of proportions, one-tailed).
Taken together, these results suggest a protective role of
regulatory T cells in our model.
Oral Administration of Inactivated
Mycobacteria spp. Increased Mice Survival
Mycobacterium tuberculosis (Mtb) heat-killed bacilli were
administered orally to C3HeB/FeJ infected mice to test their
influence on disease progression. Treatment was found to
increase survival of the mice in a statistically significant manner.
Different doses and administration patterns were tested and
positive results were obtained both when administered pre-
infection or post-infection (data not shown). The survival curve
of a representative experiment is shown in Figure 3.
Other mycobacterial species, including M. bovis Bacille-
Calmette-Guérin (BCG) and environmental species, were
also tested. Animals treated with heat-killed BCG, M.
kansasii (data not shown) and M. manresensis, a newly
discovered environmental mycobacteria species belonging to
the M. fortuitum complex (CECT 8638) (Rech et al., 2015)
showed an increased survival compared to untreated controls
(Figure 3). This protection was also achieved when giving
the same treatment with the same concentration of living
M. manresensis (data not shown). As was the case for Mtb,
different doses and administration schedules were tested for all
of these strains and positive results were obtained both when
administered pre-infection or post-infection (data not shown).
Oral treatment with M. avium was also tested but found not to
improve mice survival (data not shown).
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FIGURE 1 | Flow cytometry analysis carried out. CD3+CD4+ T cells were classified into 4 groups: CD25+CD39+ Regulatory Memory T cells; CD25-CD39+
Effector Memory T cells, ex-Tregs IL-17 producers; CD25+CD39− T Effector cells and CD25-CD39− Naïve T cells.
Oral Administration of Heat-Killed
Mycobacteria Reduced Lung Pathology
The effect on lung pathology was evaluated for oral treatments
with three different heat-killed mycobacteria, namely Mtb,
BCG and M. manresensis. Figure 4 shows how all treatments
significantly reduced the infiltration in the parenchyma
(statistically significant differences: p = 0.0002; Mann Whitney
test). Figure 5 shows one of the H/E recuts, which was used to
measure the percentage damaged area, for the untreated control
group and the group treated with M. manresensis. In agreement
with the histometry analysis, the picture enclosed in Figure 5
shows the presence of fewer and smaller lesions in the lungs of
treated mice than in the untreated control group.
Oral Administration of Heat-Killed
Mycobacteria Decreases Lung Bacillary
Load
The effect on bacillary load in lungs was evaluated for oral
treatments with three different heat-killed mycobacteria, namely
Mtb, BCG and M. manresensis. The three treatments decreased
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FIGURE 2 | Role of Treg in TB-resistant C3H/HeN mice strain. Treg Foxp3+ population was studied in C3HeB/FeJ and C3H/HeN mice in splenocytes
(A,B). Splenocytes obtained on day 21 post-infection (A), statistically significant differences (**p = 0.0022, Mann Whitney test); each circle represents an animal and
the median is represented with a line. Splenocytes obtained on day 14 post-infection were cultured for 7 days with PPD stimulus (PPD) or with no stimulation
(MCC) (B), statistically significant differences between groups (*p < 0.05; Mann Whitney test); the boxplot shows the median, quartiles and minimum and maximum
values. A Treg-depletion study was performed and lung pathology was studied in depleted and undepleted animals (C–F). Treg depletion was confirmed by measuring
the percentage of Treg Foxp3+ cells at different time points (C). Percentage of damaged area out of total lung area (D); each circle represents an animal and the lines
are medians. Proportion of animals with mild or severe affection in lungs in control undepleted group and Treg depleted group (E); bars indicate number of animals.
H/E stained lung recuts showing mild and severe infection (F).
the BL in lungs at day 21 post-infection in a statistically
significant manner (BCG p = 0.0317, Mtb p = 0.0079,
M. manresensis p = 0.0079; Mann Whitney test) as shown in
Figure 6.
Immuno-Characterization of Heat-Killed
Mycobacteria Treatment
The immunomodulation achieved by the oral treatment
with heat-killed Mtb, BCG and M. manresensis was also
characterized. Flow cytometric analysis of splenocyte cultures
was used to assess different CD4+ T cell populations (M&M,
Section PPD-specific T cell population analysis by flow
cytometry). The results are shown in Figure 7 (M. manresensis
treatment) and Supplementary Image 1 (Mtb, BCG, and M.
manresensis treatments). The naïve CD25-CD39− population,
which represents the higher percentage of CD3+CD4+ cells,
tended to be higher under unstimulated conditions than under
PPD stimulation. In contrast, the CD25+CD39− population,
which represented approximately 2% of CD3+CD4+ cells,
did not show any major differences between stimulated and
non-stimulated culture conditions. A mild increase in this
population was observed when cells were cultured for 7 days.
We also observed this trend in CD25+CD39+ Regulatory
T cells, which represent around 2–9% of all CD3+CD4+
cells. In contrast to naïve T cells, this population tends to be
higher under PPD stimulation. Furthermore, a higher PPD-
specific response of CD25+CD39+ was observed in splenocytes
from mice treated with M. tuberculosis and M. manresensis in
comparison to untreated mice, but only when cells were cultured
for 7 days (statistically significant differences: Mtb p = 0.0159,
M. manresensis p = 0.0079; MannWhitney test).
The CD25-CD39+ population accounts for about 20% of all
CD4+ T cells. A higher percentage of PPD-stimulated cells (with
statistically significant differences) is observed when cultured for
4 days, with levels of both stimulated and unstimulated cells
decreasing after culture for 7 days.
Cytokine Profile
We studied the presence of different cytokines in the splenocyte
supernatant and lung homogenates of control untreated mice
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FIGURE 3 | Effect of treatment on survival. The survival curves for three
different oral treatments are represented together with the survival curve for
the untreated control group. Infected C3HeB/FeJ mice were treated every
other day for 2 weeks from infection day with 105–106 heat-killed
bacilli/animal. Statistically significant differences were observed between
untreated mice and mice treated with heat-killed BCG (p = 0.0038), Mtb
(p = 0.0029), or M. manresensis (p < 0.0001) (Log-rank Test).
FIGURE 4 | Effect of treatment on lung pathology: histometric analysis.
Infected C3HeB/FeJ mice were treated every other day for 2 weeks from
infection day with 105–106 heat-killed bacilli/animal. The percentage of
damaged area out of total lung area was studied in each treatment group on
samples obtained on day 21 post-infection. Each circle represents an animal
and the lines are medians. Statistically, significant differences were observed
between untreated mice and mice treated with heat-killed mycobacteria
(***p = 0.0002; Mann Whitney test).
or mice treated with heat-killed M. manresensis. Mice treated
with M. manresensis showed higher levels of pro-inflammatory
cytokines but a reduced inflammatory milieu in lungs when
compared to control mice. Detailed results are shown in Figure 8.
In splenocyte culture, treated mice showed a statistically
significant increase in IFNγ, TNFα, IL-6, and IL-10 levels in
spleens, whereas they showed a statistically significant decrease
in IFNγ, TNFα, IL-6, and IL-17 levels in lung homogenates.
IL-5 levels could not be detected in any sample, thus
suggesting a poor Th2 response.
Heat-Killed Mycobacteria as Coadjuvant
Therapy
The effect of heat-killed M. manresensis on mice survival when
administered as coadjuvant treatment to RHEZ was evaluated,
with M. manresensis-treated mice showing a statistically
significant increase in survival (p < 0.0001, Log-rank test;
FIGURE 5 | Effect of treatment on lung pathology: macroscopic view of
lesions. HE-stained lung recuts of untreated control mice (A) or mice treated
with heat-killed M. manresensis (B) of samples obtained on day 21
post-infection.
FIGURE 6 | Effect of treatment on bacillary load in lungs. Infected
C3HeB/FeJ mice were treated every other day for 2 weeks from infection day
with 105–106 heat-killed bacilli/animal. BL in lungs obtained on day 21 post
infection is expressed as log CFU/ml. The boxplot shows the median, quartiles
and minimum and maximum values, with a different pattern for each treatment
group. Statistically, significant differences were observed between treated and
untreated control mice (BCG: *p = 0.0317, Mtb: **p = 0.0079, M.
manresensis: **p < 0.0079; Mann Whitney test).
Figure 9). Comparison of the histopathology between the
animals from the control group that had to be euthanized
according to the welfare monitoring control (between weeks
15 and 22 post-infection) with the survivors from the
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FIGURE 7 | Effect of treatment with heat-killedM. manresensis on T cell populations in the spleen. Percentage of the four populations defined by CD25 and
CD39 markers (out of the total of CD3+CD4+ cells). Splenocytes obtained on day 21 post-infection were cultured for 24 h, 4 days, or 7 days with PPD stimulus (PPD)
or without stimulation (MCC). The boxplot shows the median, quartiles and minimum and maximum values, with a different color for each treatment. Statistically,
significant differences are marked with asterisks (*p < 0.05, **p < 0.01; Mann Whitney test).
FIGURE 8 | Cytokine profile in spleen and lungs. Effect of treatment of infected C3HeB/FeJ mice every other day for 2 weeks with heat-killed M. manresensis.
Samples were obtained on day 21 post-infection. Each circle represents an animal and the median is represented with a line. Cytokine levels are expressed as pg/ml.
Statistically, significant differences are marked with asterisks (*p < 0.05, **p < 0.01; Mann Whitney test).
M. manresensis-treated group that were euthanized to terminate
the experiment (week 24) showed a clear difference in terms
of intrapulmonary infiltration (51 vs. 68%; p = 0.0059, Mann
Whitney test; Figure 10). Looking at the quality of the lesions
(Figure 11), all the samples of the control group showed a
massive necrosis with liquefaction in the center and big patches
of massive accumulation of nuclear debris plenty of bacilli. In the
case of the group treated with M manresensis lesions resembled
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granulomas of chronic tuberculosis infection seen in resistant
mice (C57BL/6) where the bacilli are accumulated in foamy
macrophages (FM), and where big cholesterol crystals can be
seen as described before (Cardona et al., 2003; Cáceres et al.,
2009). There is also a progressive fibrosis of the parenchyma
caused by the proliferation of the fibroblasts of the alveolar
wall, in a honeycomb pattern as described by Dunn and North
(1996). The difference is that there are little infiltrations of PMN,
especially around the infected FM. Different animals have lesions
with different degrees of evolution, and it can be seen how this
PMN infiltration become bigger and is infected with bacilli, that
multiplies over them, as described before (Marzo et al., 2014).
DISCUSSION
The data provided herein suggest, for the first time, that a low
dose tolerance regimen (i.e., administration of 105 heat-killed
M. manresensis daily for 14 days) could be used to control
FIGURE 9 | Heat-killed M. manresensis as a coadjuvant therapy.
Survival curves for infected C3HeB/FeJ mice treated with RHEZ (red line) or
RHEZ in combination with heat-killed M. manresensis (Mn) (blue line).
Treatment started at week 4 post-infection, RHEZ therapy was administered
for 4 weeks and Mm therapy lasted 6 weeks.
progression toward active TB. This treatment regimen seems to
interfere with the excessive inflammatory response, a fact that
appears to be key to the development of human-like lesions
(Cardona, 2015), and thus is also able to reduce the bacillary
concentration in lungs (Marzo et al., 2014). In our opinion, this
could be related to the induction of Tregs.
It is well established that dose and route of administration
determine the immune response to an administered antigen
(Faria andWeiner, 2005), therefore we have good reason to think
that our regimen induces tolerance to the mycobacteria bacilli.
Continuous oral administration modifies the response triggered
by the infection through Tregs, as has also been seen in other
infectious or autoimmune diseases (Harats et al., 2002; Ochi et al.,
2006; Levy and Ilan, 2007; Weiner et al., 2011).
We have shown that treatment with heat-killed bacilli is
effective for reducing both the infiltration area and the bacillary
load in lungs, in addition to increasing survival. As such, we
then decided to further characterize the effect of treatment on the
immune system to prove that tolerance is induced.
In this regard we first investigated the role of Tregs in our
model as it was feasible that oral tolerance could be articulated
through this type of cell. The role of Tregs in Mtb infection
is controversial, with some authors considering the induction
of Tregs to be detrimental (Ribeiro-Rodrigues et al., 2006;
Chiacchio et al., 2009) but others pointing to a protective role
for Tregs (Leepiyasakulchai et al., 2012). To investigate the
role of Tregs in our experimental system we compared the
Treg population in C3HeB/FeJ mice with their positive controls
(C3H/HeN mice), which share the MHC haplotype but have a
different susceptibility to Mtb (Marzo et al., 2014). We found
that the better outcome was associated with a stronger regulatory
immune response in the C3H/HeN strain, as the Treg percentage
was higher (also PPD-specific response), and when we depleted
C3H/HeN mice of Treg by administration of anti-CD25 the
susceptibility to Mtb increased. Two out of five mice developed
necrotic lesions, whereas in several experiments conducted by
our group with this mouse strain, no animals have either died
FIGURE 10 | Heat-killed M. manresensis as a coadjuvant therapy: histometric analysis. Macroscopic view of HE-stained lung recuts from mice treated with
RHEZ (A) or treated with RHEZ and heat-killed M. manresensis (B). The percentage of damaged area out of total lung area was studied in both groups (C). Each
circle represents an animal and the lines are medians. Statistically, significant differences were observed between untreated mice and mice treated with heat-killed
mycobacteria (**p = 0.059; Mann Whitney test).
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FIGURE 11 | Heat-killed M. manresensis as a coadjuvant therapy: qualitative histological analysis. Pulmonary infiltration in mice treated with RHEZ and
heat-killed M. manresensis at week 24 post-infection (A,B,D,E) is compared with mice only treated with RHEZ that had to be euthanized according to the welfare
monitoring control (C,F). Pictures (A) and (B) show the haematoxylin-eosin (HE) and Masson trichromic (MTC) stains respectively showing the structure of murine
chronic TB infection with a lot of foamy macrophages and where cholesterol crystals (marked with arrows) can be seen. MTC stain showing the honeycomb patron
caused by the progressive fibrosis originated at the alveolar wall. Pictures (D) and (E) show the localization of bacilli with the Ziehl-Neelsen (ZN) stain, initially only in
foamy macrophages (D) to growth on PMN rafts (marked with asterisks) afterwards (E). Picture C shows the accumulation of cellular debris, which is the main
property of the infiltration in terminal mice, after HE stain. Massive bacillary presence is shown with ZN stain in picture (F).
or developed such necrotic lesions. Although, T CD4+CD25+
cells include Tregs as well as potential T CD4+CD25+CD39−
Th subsets (Dwyer et al., 2010), the latter account for about 1%
of all T CD4+, therefore Treg depletion is far more relevant.
Taken together, these results strongly support the hypothesis that
Tregs are protective in TB, therefore we continued our research
by studying the effect of treatment with heat-killed mycobacteria
on Tregs.
As we were interested in the induction of memory Tregs,
we designed the concept of 7 days incubation, together with a
study of the CD39 marker. We believe this marker to be very
relevant as it has been related to both the memory phenotype and
induction of tolerance (Borsellino et al., 2007; Dwyer et al., 2010;
Roberts et al., 2014). Furthermore, unlike Foxp3, it is a surface
marker, which translates into less aggressive cell processing and
easier and faster protocols. Other relevant T cell subtypes, such
as T memory effector cells CD25-CD39+, which have shown to
play a detrimental role in organ transplantation in humans, or
T effector cells, both of which are capable of secreting IL-17,
and thus having a pro-inflammatory profile (Dwyer et al., 2010),
were also studied with the marker combination used. Apart from
being used in the study of autoimmune diseases, this CD25 CD39
marker combination has been validated as a Treg marker in the
study of TB, exhibiting a negative correlation with IL-17 T cells in
peripheral blood (Chiacchio et al., 2009; de Cassan et al., 2010).
Use of these markers showed an increase in Treg cells in
splenocyte cultures from treated mice, together with a slight
global stimulation. The levels of IFN-γ, TNF, and IL-6 were
increased in cultured spleen samples from mice treated with
M. manresensis. This suggest a global stimulation that also
includes an increase in the immunosuppressive cytokine IL-10,
which can be related to the increase in Treg, as seen by other
authors who used 106 heat-killed M. chelonae intraperitoneally
once a week for 3 weeks (Ho et al., 2010). In that study, the
authors also demonstrated a parallel increase in IFN-γ, although
they did not check for IL-6 or TNF. The most important aspect,
however, is that the increase in IL-6 was not linked to the
presence of IL-17 (Gao et al., 2009), which was undetectable,
and this is logical as an exaggerated inflammatory response with
neutrophilic attraction is not seen in the spleen in the C3HeB/FeJ
model, where there is also effective control of bacillary load (data
not shown). This could be due to the fact of the presence of Treg
counterbalancing IFN type I production (Srivastava et al., 2014;
Aida et al., 2014), thus favoring the increased IFNγ response
(Manca et al., 2001); or because of the lack of PMN infiltration
in the spleen prevents the production of type I IFN (Berry et al.,
2010), thus favoring the presence of both Tregs and IFN-gamma
in this organ in the context of Mtb infection. However, further
experiments would be needed to investigate this issue.
A lower inflammatory milieu was found in the lungs of mice
treated with M. manresensis when compared to control animals,
with lower levels of IFNγ, TNFα, IL-17, and IL-6. In our opinion,
the population of PPD-specific memory Tregs is attracted to
the lungs and must be crucial for reducing the inflammatory
response in situ, specially by counterbalancing the Th17 response
(Zhou et al., 2008; Zheng et al., 2013).
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Lung histopathology of mice treated with RHEZ shows how
the addition of heat-killed M. manresensis is able to stop the
progression of the lesions, favoring the fibrosis of the tissue which
might contribute to create an anti-inflammatory milieu able to
abrogate the growth of the bacilli by curtailing the infiltration
of the lesion with monocytes or PMN. This phenomenon is
amplified in big-mammals thanks to the stimulation of the
fibroblasts of the intralobar septae, that encapsulate the lesions
at very early stages, promoting this anti-inflammatory milieu
and stopping the bacillary growth (Gil et al., 2010; Cardona,
2015).
The modulatory effect of NTM was demonstrated years ago
after intravenous inoculation was shown to induce a non-specific
cellular immune response (Collins, 1971) and protect against
subsequent aerosol Mtb infection to a similar degree as in BCG
vaccinated mice (Orme and Collins, 1984). On the other hand,
subcutaneous sensitization with M. avium interfered with BCG
vaccination by stopping its growth, although this was not seen
after sensitization withM. chelonae orM. fortuitum (Brandt et al.,
2002). The recent study by Poyntz et al. (2014) is interesting as
it shows how important the route of administration for NTM
is (in this case, M. avium). An increase in Th1 response can be
detected when inoculating heat-killed IP several times, thereby
increasing the efficacy of BCG, whereas oral administration of
living bacilli tended to increase Th2 response in the lung during
Mtb infection and reduced the protection against Mtb infection.
Treatment with heat-killed Mycobacterium vaccae, which has
been used for the treatment of active TB (von Reyn et al., 2010)
and has recently been reviewed by Gröschel et al. (2014), deserves
particular attention due to its ability to reduce Th2 responses and
increase Th1 ones.
Finally, it is relevant to recall that studies in BCG-vaccinated
infants in the United Kingdom or in Malawi showed no evidence
that the initial response to NTM affected the vaccine-induced
change in IFN-γ response (Weir et al., 2006). In this regard, it
is interesting to note that, to date, no surrogates of protection
have been found in TB. Th1 responses, including poly-functional
cells, have received attention for a number of years, although
an evaluation of their protective value in a large BCG trial in
South Africa showed that protected and unprotected newborns
exhibited an equivalent immunological profile (Kagina et al.,
2010). In this sense, our paper may also help to shed some
light on other biomarkers that are more closely related to the
induction of a balanced immune response and are able to avoid
an excessive inflammatory response than can lead to active TB,
instead of focussing on an immune response that exclusively
targets destruction of the bacilli.
In conclusion, induction of a balanced immune response
triggered by PPD-specific memory Tregs through the
administration of heat-killed M. manresensis has demonstrated
an ability to protect against the progression of Mtb infection
to active disease and relapse after TB treatment. This has been
demonstrated in the experimental model induced in C3HeB/FeJ
mice, which reproduce “human-like” lesions. This finding might
help to focus on a new kind of “host-directed” prophylactic
and therapeutic approach as well as the development of new
predictive biomarkers.
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